{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T04:07:22Z","timestamp":1752984442320,"version":"3.40.5"},"reference-count":10,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CCID"],"DOI":"10.2147\/ccid.s330354","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T08:40:16Z","timestamp":1630053616000},"page":"1125-1129","source":"Crossref","is-referenced-by-count":5,"title":["Pemphigus Herpetiformis-Type Drug Reaction Caused by Programmed Cell Death Protein-1 Inhibitor Treatment"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Yunfang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-6936","authenticated-orcid":true,"given":"Weiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiejie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"103376","DOI":"10.1016\/j.critrevonc.2021.103376","volume":"163","author":"Han","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1158\/2326-6066.CIR-15-0123","volume":"4","author":"Naidoo","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/ijd.14395","volume":"58","author":"Costa","year":"2019","journal-title":"Int J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/bjd.12925","volume":"171","author":"Yoshimura","year":"2014","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1080\/15569527.2016.1254650","volume":"36","author":"Akoglu","year":"2017","journal-title":"Cutan Ocul Toxicol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cup.14004","author":"Svoboda","year":"2021","journal-title":"J Cutan Pathol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2050313X18809268","DOI":"10.1177\/2050313X18809268","volume":"6","author":"Haydock","year":"2018","journal-title":"SAGE Open Med Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fmed.2019.00262","volume":"6","author":"Krammer","year":"2019","journal-title":"Front Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fmed.2019.00249","volume":"6","author":"Yatim","year":"2019","journal-title":"Front Med"},{"key":"ref10","unstructured":"BeiGene. Tislelizumab; China prescribing information [Chinese]; 2019. Available from: http:\/\/drugs.medlive.cn\/drugref\/html\/21697.shtml. Accessed March, 10 2020."}],"container-title":["Clinical, Cosmetic and Investigational Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=73066","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=73066","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T08:40:20Z","timestamp":1630053620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/pemphigus-herpetiformis-type-drug-reaction-caused-by-programmed-cell-d-peer-reviewed-fulltext-article-CCID"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":10,"URL":"https:\/\/doi.org\/10.2147\/ccid.s330354","relation":{},"ISSN":["1178-7015"],"issn-type":[{"type":"electronic","value":"1178-7015"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}